Philips convenes the Annual General Meeting of Shareholders 2026
Rhea-AI Summary
Royal Philips (NYSE: PHG) has convened its Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. The AGM is scheduled for Friday, May 8, 2026 at 10:00 CET at Hotel Okura Amsterdam.
Key items include the proposed appointment of John DeFord to the Supervisory Board; re-appointments of Paul Stoffels, Herna Verhagen, and Sanjay Poonen; and re-appointment of Roy Jakobs as President/CEO and Board of Management member, all effective May 8, 2026. The agenda also covers the 2025 Remuneration Report (advisory), a proposed Supervisory Board Remuneration Policy, adoption of financial statements, and dividend options.
Positive
- None.
Negative
- None.
News Market Reaction – PHG
On the day this news was published, PHG gained 2.13%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
PHG was down 2.27% while scanners showed peers like SYK and BSX modestly up and broader device peers mixed, suggesting today’s move skewed more company-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 17 | Marketing campaign | Positive | +0.2% | World Oral Health Night promotion highlighting Sonicare benefits vs manual brushing. |
| Mar 11 | Product portfolio expansion | Positive | -0.5% | Launch of cloud-enabled IntelliSite Pathology Solution on HealthSuite platform. |
| Mar 10 | Platform showcase | Positive | -1.6% | Showcased connected care intelligence and integrated diagnostics at HIMSS26. |
| Mar 05 | Consumer product launch | Positive | -4.1% | Unveiled new Sonicare toothbrush ranges and sustainability-focused upgrades. |
| Mar 04 | Imaging system launch | Positive | +1.9% | Introduced Rembra CT system for acute and high-demand imaging environments. |
Recent product and portfolio news has often been positive but produced mixed price reactions, with several instances of share price declines following seemingly constructive announcements.
Over the past weeks, Philips issued a series of product and platform updates, from the Rembra CT launch on Mar 4 (+1.94%) to new Sonicare toothbrush ranges on Mar 5 (-4.11%), digital pathology expansion on Mar 11 (-0.48%), and connected care initiatives at HIMSS26 on Mar 10 (-1.6%). The current AGM-focused announcement fits a governance and routine corporate actions theme rather than a new commercial or clinical catalyst.
Market Pulse Summary
This announcement details Philips’ 2026 AGM, including proposed Supervisory Board changes, re-appointment of the President/CEO, a new Remuneration Policy for the Supervisory Board, the 2025 Remuneration Report, and dividend proposals in cash or shares. In recent months, Philips combined such governance steps with product and platform launches that drew mixed market reactions. Investors may watch how leadership continuity and capital allocation decisions interact with these ongoing strategic initiatives.
AI-generated analysis. Not financial advice.
March 23, 2026
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes.
As previously announced, the agenda includes:
- Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.
- Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.
- Proposal to re-appoint Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and member of the Board of Management, with effect from May 8, 2026.
The agenda furthermore includes a proposal for a Remuneration Policy for the Supervisory Board as well as a number of recurring items, such as the 2025 Remuneration Report as included in the Annual Report 2025 (advisory vote), and the proposals to adopt the company’s financial statements and dividend in cash or shares.
The AGM will be held at the Hotel Okura Amsterdam, Ferdinand Bolstraat 333, Amsterdam on Friday, May 8, 2026, beginning at 10:00 CET.
The complete agenda with explanatory notes, the Annual Report 2025 (which was published on February 19, 2026), the binding nominations, the proposed Remuneration Policy for the Supervisory Board and other information relevant for the AGM have been published here.
For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 614869261
E-mail: Michael.Fuchs@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.
Attachments
FAQ
When is Royal Philips (PHG) holding its AGM 2026 and where will it be held?
Which board appointments are proposed at the Philips (PHG) AGM on May 8, 2026?
Is Roy Jakobs up for re-appointment at the Royal Philips (PHG) AGM 2026?
What remuneration items are on the Philips (PHG) AGM 2026 agenda?
Where can investors find the AGM 2026 agenda, Annual Report 2025, and related documents for Philips (PHG)?
